Changchun High-Tech Industry (Group) Co., Ltd. (SHE: 000661)

Market Cap	39.98B
Revenue (ttm)	14.27B
Net Income (ttm)	3.71B
Shares Out	402.05M
EPS (ttm)	9.04
PE Ratio	11.00
Forward PE	7.19
Dividend	4.50 (4.53%)
Ex-Dividend Date	n/a

Volume	3,832,109
Open	101.98
Previous Close	100.20
Day's Range	99.76 - 102.24
52-Week Range	77.50 - 148.00
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 21, 2025

About Changchun High-Tech Industry (Group)

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers genetic engineering pharmaceuticals, biological vaccines, modern Chinese medicines, and other pharmaceutical products; and antibody and other chemical drugs. It also develops real estate properties. Changchun High-Tech Industry (Group) Co., Ltd. was founded in 1993 and is based in Changchun, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 9,029
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000661

Financial Performance

In 2023, Changchun High-Tech Industry (Group)'s revenue was 14.57 billion, an increase of 15.35% compared to the previous year's 12.63 billion. Earnings were 4.53 billion, an increase of 9.47%.